As per the I/M for the capital raising:
To expand clinical trials beyond the current pipeline. In particular neuropathic pain and chemotherapy induced nausea.
Great news. They are bringing forward trials that were expected to be funded and commenced further down the time line.
And to confirm what a few others have said the appetite was very strong and closed within hours of going out.
